Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography–electrospray mass spectrometry
- 28 June 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 44 (2) , 558-563
- https://doi.org/10.1016/j.jpba.2006.11.020
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studiesJournal of Antimicrobial Chemotherapy, 2006
- NeurocysticercosisSeminars in Neurology, 2005
- Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosisChirality, 2004
- Therapy for neurocysticercosisExpert Review of Neurotherapeutics, 2004
- Neurocysticercosis: regional status, epidemiology, impact and control measures in the AmericasActa Tropica, 2003
- Aspects of the Pharmacokinetics of Albendazole Sulphoxide in SheepVeterinary Research Communications, 2003
- Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosisBritish Journal of Clinical Pharmacology, 2002
- Pharmacokinetics of ricobendazole in calvesJournal of Veterinary Pharmacology and Therapeutics, 2001
- Albendazole plus praziquantel versus albendazole alone as a pre‐operative treatment in intra‐abdominal hydatidosis caused by Echinococcus granulosusTropical Medicine & International Health, 1998
- Small intestinal sulphoxidation of AlbendazoleXenobiotica, 1995